News
U.S. delays Trump’s new tariffs on pharmaceuticals
The new tariffs on pharmaceutical imports into the United States, announced by President Donald Trump for October 1, have been postponed for now, according to government sources. Instead, the Trump administration will begin preparing tariffs targeting pharmaceutical companies that refuse to relocate production to the U.S. or lower their prices, a senior U.S. official said on Thursday, without giving a reason for the delay.
Earlier, Mr Trump had unexpectedly announced that a 100 per cent tariff would take effect from October 1 on imports of branded and patented medicines into the U.S. Pharmaceutical companies could avoid the tariffs by building production facilities in the U.S., though details were unclear. Just before the planned start date, U.S. officials clarified that the European Union would be exempt from the new rules on pharmaceutical products, with EU imports continuing to face a 15 per cent tariff. (dpa/NAN)
-
Stock Market2 days agoNGX All-Share Index, market capitalisation each rose
-
Oil and Gas2 days agoOil prices slide about 2% to multi-week low amid peace talks
-
Oil and Gas2 days agoNNPC IPO will likely start with 5% to 10% listing, CEO says
-
News2 days agoLagos IGR made up 67.72 per cent of the state’s recurrent revenue, others rely on FACC allocation—BudgIT
-
Economy23 hours agoStates budgets exceed available funding, risking stalled projects, payment arrears—WBG
-
Oil and Gas2 days agoEFCC raids Chinese illegal oil refinery in Ogere Ogun
-
News2 days agoAfCRA to publish first African sovereign credit ratings March 2027
-
Economy2 days agoEfficient Civil Service key to achieving $1tn economy by 2030—FCSC chairman